Your Messages Inbox
Your Article Summary
See Latest ArticlesTrial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis
PLoS Medicine, 09/14/09
Ross JS et al. – Reporting of optional data elements varied and publication rates among completed trials registered within ClinicalTrials.gov were low. Without greater attention to reporting of all data elements, the potential for ClinicalTrials.gov to address selective publication of clinical trials will be limited.
Related Articles
Oral or transdermal opioids for osteoarthritis of the knee or hip
Cochrane Reviews, 10/13/09
Relevance Score: 94%
Enriched Enrollment Randomized Withdrawal Trial Designs of Analgesics: Focus on Methodology
The Clinical Journal of Pain, 10/21/09
Relevance Score: 91%
Centralized Review Process Markedly Expedites Approval of Cancer Clinical Trials
NIH, 10/20/09
Relevance Score: 91%
Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials
Intensive Care Medicine, 10/05/09
Relevance Score: 91%
Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial
Boston Scientific, 10/06/09
Relevance Score: 90%
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
MediGene AG Decides on a Revision of the Development Plans for EndoTAG(TM)-1 and RhuDex(TM), and Downsizes its Executive Board
MediGene, 12/15/09
Second Pivotal Phase III Study of Gileads Darusentan for Resistant Hypertension Misses Primary Endpoints
Gilead, 12/15/09
Genentech and Biogen Idec Announce Positive Results From First Phase III Trial of Ocrelizumab in Rheumatoid Arthritis
Genentech, 12/15/09
Article Search
Sponsor